Sartorius AG. (3/5/19). "Press Release: Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography". Göttingen.

	Organisation	Sartorius Stedim Biotech GmbH (SSB)
	Group	Sartorius (Group)
	Organisation 2	Novasep S.A.
	Group	Novasep (Group)
	Product	chromatography
	Product 2	BioSC® Lab continuous biochromatography equipment
	Index term	Novasep–Sartorius: chromatography, 201903– collab developm of systems for membrane chromatography SSB
	Person	Linz, Fritjof (Sartorius 201903 Head of Separation at SSB)
	Person 2	Laborde, Nadège (Novasep 201311– President of Industrial Biotech business unit joined Novasep 2000)

Sartorius Stedim Biotech (SSB), a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. Novasep provides various products and services to the life science industry, based on specialized technologies. In particular, this company is a recognized system provider with substantial expertise in the design, manufacture and control of resin-based batch and continuous chromatography systems.

Novasep’s established BioSC® platform and SSB’s single use technology will form the basis for the development of innovative chromatography systems. Systems currently on the market are designed for resins, but do not take full advantage of membrane chromatography capabilities. Optimally run membrane chromatography processes will provide the most attractive alternative to batch and continuous resin-based chromatography - namely higher productivity, smaller scale operations and increased robustness.

Systems designed for membrane chromatography applications are a part of SSB’s global product strategy to supply complete solutions for upstream and downstream processing in life sciences. “Membranes are the embodiment of process intensification. As the market leader in membrane chromatography, Sartorius Stedim Biotech aims to realize this potential and offer customers the full benefits of our Sartobind portfolio,” explained Dr. Fritjof Linz, Head of Separation at Sartorius Stedim Biotech. “We are happy to work with a highly competent partner like Novasep to introduce new membrane chromatography technology for flow through and capture applications,” the Sartorius manager added.

Nadège Laborde, President Process Solutions at Novasep, commented: “This collaboration is a wonderful opportunity for Novasep and Sartorius Stedim Biotech, as it leverages the core capabilities of the two companies. The result of this venture will satisfy the latest market demands for continuous processing, process intensification, performance, and ease of use.”

This press release contains statements about the future development of the Sartorius Stedim Biotech Group. We cannot guarantee that the content of these statements will actually apply because these statements are based upon assumptions and estimates that harbor certain risks and uncertainties.

About Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2018, the company employed approx. 5,600 people, and earned sales revenue of €1,212.2 million.

About Novasep

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries. http://www.novasep.com

Contact:

Dominic Grone, Communications Manager, Sartorius Stedim Biotech GmbH, Tel.: +49 (0)551.308.3324; email: dominic.grone@sartorius.com

Record changed: 2019-03-06